Connect with us

Hi, what are you looking for?


Emerson stock should be worth $105, analyst says

Emerson Electric Co (NYSE: EMR) down more than 10% for the year is an opportunity to buy a quality name at a deep discount, says Joseph O’Dea – a Wells Fargo analyst.

Emerson stock could climb 23% from here

On Thursday, O’Dea upgraded the engineering services company to “overweight” and raised his price objective to $105 that translates to a 23% upside from here.

The analyst is bullish on Emerson stock primarily for the company’s exclusive focus on industrial automation. His research note reads:

There’s arguably more upside to valuation for a high margin, pure play automation company. We’d expect that to be realised through solid operational and integration execution.

Emerson Electric is scheduled to report its Q2 results on May 3rd. Consensus is for it earn 97 cents a share this quarter versus $1.29 per share a year ago.

Jim Cramer agrees with the bullish view

A prominent reason why Emerson stock has underperformed in 2023 was its hostile bid for National Instruments Corp.

Last week, though, the Fortune 500 company confirmed that “NATI” has agreed to be acquired for $60 a share. Emerson expects the said agreement to be accretive not only to growth but also help improve its margin profile.

Remember that “EMR” is a dividend stock that currently pays a yield of 2.41% – an additional reason to own it.

Also on Thursday, famed investor and Mad Money host Jim Cramer also agreed that the company’s shares were indeed undervalued at current levels. Last year, Blackstone announced a majority stake in Emerson’s Climate Technologies unit as Invezz reported HERE.

The post Emerson stock should be worth $105, analyst says appeared first on Invezz.

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Latest News

    Rep. Jennifer Wexton (D-Va.) announced on Tuesday that she has been diagnosed with Parkinson’s Disease. “If there’s one thing that Democrats and Republicans can...

    Latest News

    After Dianne Feinstein announced she’d contracted the shingles in early March, her staff said she planned to return to the Senate within a matter...


    A U.S. District Court judge has ruled that Elizabeth Holmes, founder and CEO of the disgraced blood-testing company Theranos, cannot remain free on bail...

    Latest News

    SEOUL, South Korea — When a group of American lawmakers arrived in South Korea for meetings with government and military officials, President Yoon Suk-yeol...

    Disclaimer:, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2022 All Rights Reserved.